Goldman Sachs’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-28,200
| Closed | -$938K | – | 5652 |
|
|
2020
Q2 | $938K | Buy |
+28,200
| New | +$898K | ﹤0.01% | 3997 |
|
|
2018
Q1 | – | Sell |
-2,000
| Closed | -$28K | – | 6552 |
|
|
2017
Q4 | $28K | Sell |
2,000
-1,800
| -47% | -$24.3K | ﹤0.01% | 6063 |
|
|
2017
Q3 | $70K | Sell |
3,800
-4,600
| -55% | -$76.9K | ﹤0.01% | 6177 |
|
|
2017
Q2 | $142K | Buy |
8,400
+2,000
| +31% | +$30.4K | ﹤0.01% | 5974 |
|
|
2017
Q1 | $85K | Buy |
6,400
+4,100
| +178% | +$64.2K | ﹤0.01% | 6124 |
|
|
2016
Q4 | $35K | Buy |
2,300
+500
| +28% | +$6.6K | ﹤0.01% | 6486 |
|
|
2016
Q3 | $21K | Buy |
1,800
+1,100
| +157% | +$12.9K | ﹤0.01% | 6742 |
|
|
2016
Q2 | $8K | Sell |
700
-51,000
| -99% | -$526K | ﹤0.01% | 6891 |
|
|
2016
Q1 | $478K | Sell |
51,700
-15,900
| -24% | -$171K | ﹤0.01% | 4780 |
|
|
2015
Q4 | $1M | Sell |
67,600
-111,700
| -62% | -$1.87M | ﹤0.01% | 4293 |
|
|
2015
Q3 | $2.94M | Buy |
179,300
+94,700
| +112% | +$1.94M | ﹤0.01% | 3397 |
|
|
2015
Q2 | $1.93M | Buy |
84,600
+79,600
| +1,592% | +$1.59M | ﹤0.01% | 3862 |
|
|
2015
Q1 | $76K | Sell |
5,000
-7,000
| -58% | -$90.9K | ﹤0.01% | 6549 |
|
|
2014
Q4 | $144K | Sell |
12,000
-77,100
| -87% | -$881K | ﹤0.01% | 6387 |
|
|
2014
Q3 | $1.01M | Buy |
89,100
+68,500
| +333% | +$781K | ﹤0.01% | 4604 |
|
|
2014
Q2 | $249K | Sell |
20,600
-79,700
| -79% | -$941K | ﹤0.01% | 6026 |
|
|
2014
Q1 | $1.17M | Sell |
100,300
-1,500
| -1% | -$25.4K | ﹤0.01% | 4516 |
|
|
2013
Q4 | $1.8M | Sell |
101,800
-142,700
| -58% | -$2.4M | ﹤0.01% | 4187 |
|
|
2013
Q3 | $3.52M | Buy |
244,500
+214,000
| +702% | +$3.28M | ﹤0.01% | 3332 |
|
|
2013
Q2 | $459K | Buy |
+30,500
| New | +$403K | ﹤0.01% | 5012 |
|
Goldman Sachs's MNTA Position: Q4 2020 in Review
Goldman Sachs sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 1,610,731 shares — an estimated $84.5M sold.
Goldman Sachs first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $84.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Goldman Sachs reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Goldman Sachs sold 1,610,731 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $84.5M.
- Goldman Sachs first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Goldman Sachs's Momenta Pharmaceuticals, Inc. position peaked at $84.5M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.